本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Senti Biosciences, Inc.

0.3060
+0.00581.93%
盤後0.30940.0034+1.11%19:30 EDT
成交量:11.25萬
成交額:3.50萬
市值:953.02萬
市盈率:-0.18
高:0.3199
開:0.3000
低:0.3000
收:0.3002
52周最高:2.88
52周最低:0.2900
股本:3,114.45萬
流通股本:1,457.74萬
量比:0.64
換手率:0.77%
股息:- -
股息率:- -
每股收益(TTM):-1.7136
每股收益(LYR):-2.7326
淨資產收益率:-466.46%
總資產收益率:-65.57%
市淨率:-2.80
市盈率(LYR):-0.11

資料載入中...

2026/09/04

重要事件披露

Form 8-K - Current report
2026/09/03

重要事件披露

Form 8-K - Current report
2026/08/20

重要事件披露

Form 8-K - Current report
2026/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/15

重要事件披露

Form 8-K - Current report
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

重要事件披露

Form 8-K - Current report
2026/05/01

重要事件披露

Form 8-K - Current report
2026/04/30

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026/04/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/04/24

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/04/24

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/04/24

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/04/24

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/04/01

重要事件披露

Form 8-K - Current report
2026/03/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/27

重要事件披露

Form 8-K - Current report
2026/03/19

重要事件披露

Form 8-K - Current report
2025/12/09

重要事件披露

Form 8-K - Current report